ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628917 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628917; 2) Community: the network communities that were significantly associated with the response to NSC 628917; 3) Molecule: the relationships between components within communities and NSC 628917; 4) MDR: the compounds that were significantly associated with the NSC 628917.

NSC Compound Enrichment Correlation
NSC 743874 Null 0.0177048892222174 0.49314129
NSC 746684 7-{[3-(dibutylamino)propyl]amino}-5-imino-1,3,6-triphenyl-5,6-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dithione 0.0177048892222174 0.37372658
NSC 751830 2-(4-hydroxypiperidin-1-yl)-4-(4-morpholinophenylamino)pyrido[4,3-d]pyrimidin-5(6H)-one 0.0177048892222174 0.012227589
NSC 7534 SCILLIROSIDIN, GLYCOSIDE 0.0177048892222174 0.52826681
NSC 757424 Mycophenolic acid (USAN) 0.0177048892222174 0.52029222
NSC 759852 Vorinostat (USAN) 0.0177048892222174 0.28424225
NSC 163443 Null 0.0193573267900279 0.19092476
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0193573267900279 0.44547073
NSC 339137 PHYSALOLACTONE 0.0193573267900279 0.41572531
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0193573267900279 0.54774012
Total:106  Current:51    [First] [Prev] [Next] [Last]